- Home
- BCC vs APLS Comparison
BCC vs APLS Comparison
Compare BCC & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCC
- APLS
- Stock Information
- Founded
- BCC 2004
- APLS 2009
- Country
- BCC United States
- APLS United States
- Employees
- BCC N/A
- APLS N/A
- Industry
- BCC RETAIL: Building Materials
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- BCC Consumer Discretionary
- APLS Health Care
- Exchange
- BCC Nasdaq
- APLS Nasdaq
- Market Cap
- BCC 2.6B
- APLS 2.9B
- IPO Year
- BCC 2013
- APLS 2017
- Fundamental
- Price
- BCC $68.96
- APLS $20.39
- Analyst Decision
- BCC Strong Buy
- APLS Buy
- Analyst Count
- BCC 7
- APLS 19
- Target Price
- BCC $102.50
- APLS $32.83
- AVG Volume (30 Days)
- BCC 466.0K
- APLS 3.4M
- Earning Date
- BCC 11-03-2025
- APLS 10-30-2025
- Dividend Yield
- BCC 1.27%
- APLS N/A
- EPS Growth
- BCC N/A
- APLS N/A
- EPS
- BCC 5.07
- APLS 0.36
- Revenue
- BCC $6,511,894,000.00
- APLS $1,016,397,000.00
- Revenue This Year
- BCC N/A
- APLS $25.39
- Revenue Next Year
- BCC $3.58
- APLS N/A
- P/E Ratio
- BCC $13.62
- APLS $56.77
- Revenue Growth
- BCC N/A
- APLS 42.11
- 52 Week Low
- BCC $65.62
- APLS $16.10
- 52 Week High
- BCC $155.42
- APLS $35.72
- Technical
- Relative Strength Index (RSI)
- BCC 38.76
- APLS 39.49
- Support Level
- BCC $68.73
- APLS $18.93
- Resistance Level
- BCC $71.03
- APLS $30.48
- Average True Range (ATR)
- BCC 2.49
- APLS 1.29
- MACD
- BCC 0.18
- APLS -0.37
- Stochastic Oscillator
- BCC 42.89
- APLS 13.94
About BCC Boise Cascade L.L.C.
Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two reportable segments, namely Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber (LVL), I-joists, and laminated beams. In addition, it manufactures structural, appearance, and industrial-grade plywood panels, and ponderosa pine lumber. The Building Materials Distribution segment is engaged in the distribution of various building materials, including oriented strand board (OSB), plywood, and lumber; general line items such as siding, composite decking, doors and millwork, metal products, roofing, and insulation; and EWP, among others. The company generates a majority of its revenue from the Building Material Distribution segment.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.